Overall, our results demonstrate the rationale of targeting LOX enzymatic activity for normalizing tumor mechanical properties and ECM structure (mostly collagen fibers compaction, segregation, and linearity) in tumors exhibiting high tumor stiffness together with mechanical and structural heterogeneity. Here, LOX is linked to neoplasm.